Research in lymphoma

We strive to advance the treatments to fight lymphoma, and therefore patients, who are cared for at Institut Curie and who provide us with their authorization, have the opportunity to participate in therapeutic trials. Institut Curie is strongly involved in the clinical research network on lymphoma (LYSA – Lymphoma Study Association). As such, Institut Curie is engaged in various programs. 

In addition, Institut Curie is at the heart of the national expert network of oculocerebral lymphomas LOC, which is supported by the INCA (rare cancers plan). This referral center develops standards of care practices and regularly holds national multidisciplinary consultation meetings, during which the French centers present their files on patients suffering oculocerebral lymphoma, seeking opinion of their colleagues. 

Institut Curie is also positioning itself in translational research against lymphoma, with projects based on artificial intelligence in particular, which aim to predict the response to treatments. 

Finally, Institut Curie is part of the French academic cooperative group dedicated to chronic lymphocytic leukemia, the FILO network (French Innovative Leukemia Organization).